Medica Halstabletten Erdbeere (Chlorhexidine Dihydrochloride, Lidocaine Hydrochloride)

Chlorhexidine dihydrochloride acts by binding to bacterial cell walls and disrupting membrane integrity, leading to leakage of intracellular contents and cell death. This broad‑spectrum antiseptic effect reduces the microbial load in the throat and oral cavity, helping to alleviate infection‑related irritation.

The dosage is determined by the prescribing healthcare professional. Typically, the lozenge is allowed to dissolve slowly in the mouth, and the number of lozenges per day is set based on the severity of symptoms, patient age, and overall health status.

Safety data are limited, so the product should be used only if the potential benefit justifies any possible risk. Pregnant or nursing individuals should consult their physician before using the lozenge to ensure it is appropriate for their specific situation.

Enquiries can be submitted on the product page at gnhindia.com by entering the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with simple analgesic lozenges containing only a pain reliever such as benzocaine, Medica Halstabletten Erdbeere adds an antiseptic (chlorhexidine) that reduces bacterial presence while providing local anesthesia. This dual action can be advantageous when infection‑related irritation is a primary concern.

Store the lozenges at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and direct sunlight. Keep out of reach of children and avoid exposing the product to excessive heat or humidity.

The lozenge is taken orally and allowed to dissolve slowly in the mouth without chewing. This ensures even distribution of the active ingredients across the oral mucosa, providing both antiseptic and anesthetic effects throughout the dissolution period.

The most serious risks include allergic reactions such as rash, swelling, or difficulty breathing, and rare cases of severe oral ulceration or prolonged numbness. If any of these symptoms occur, discontinue use immediately and seek medical attention.

Individuals with a known hypersensitivity to chlorhexidine, lidocaine, or any excipients in the lozenge should avoid using it. It is also contraindicated in children under 2 years of age unless directed by a healthcare professional, and in patients with certain cardiac or hepatic conditions where lidocaine use requires caution.